InvestSMART

Epsilon Healthcare Limited (ASX:EPN)

ALERT: Price-sensitive ASX Announcement for EPN
Current share price for EPN : $0.022 -0.004 (-15.38%)+
Announcement
Release
27 Feb 2026 5:22PM
Price at Release
$0.026
Full Release
download
Summary
The Preliminary Final Report for Epsilon Healthcare Limited for the year ended 31 December 2025 highlights the company's financial performance and strategic growth initiatives. The report reveals that the primary revenue source was the Contract Development and Manufacturing (CDMO) segment, which saw significant utilization of the Southport facility, indicating operational leverage and potential for sustained growth. Telehealth services also contributed meaningfully, showcasing the company's diversified revenue model. During the period, the company successfully exited voluntary administration and focused on stabilizing operations, re-engaging clients, and restoring market confidence. This led to strong revenue growth, a streamlined cost structure, and an improved capital base. The Group's financial position includes a net asset increase to $2,989,063 and a reduction in accumulated losses compared to the previous year. Dividends were not declared, and EPS was reported as a loss of 0.54 cents per share, down from a 1.59 cents loss the prior year. The report underscores Epsilon's strategic focus and foundational strength for long-term shareholder value creation.
Key Points
  • Primary revenue from Contract Development and Manufacturing (CDMO).
  • Significant utilization of Southport facility.
  • Telehealth services contributed to diversified revenue.
  • Exited voluntary administration and focused on stabilization.
  • Strong revenue growth and streamlined cost structure.
  • Net asset increase to $2,989,063.
  • Accumulated losses reduced.
  • No dividends declared for 2025.
  • Loss per share decreased to 0.54 cents.
  • Strategic focus on long-term shareholder value.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.